VivoSeq
Other

Preterm Delivery

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Preterm Delivery is an early-stage landscape with 0 programs across 1 company. The most active players are AMAG Pharmaceuticals, Inc..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

63/100

Attrition Rate

30/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

AMAG Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

23

clinical trials

Completed12 · 52%
Terminated4 · 17%
Withdrawn3 · 13%
Unknown status3 · 13%
Recruiting1 · 4%

Clinical Trials

Trial Activity

23 trials

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Recruiting·TThe George Washington University Biostatistics Center·Phase 3·NCT06980025·1,800 enrolled
Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone
Completed·HHillel Yaffe Medical Center·N/A·NCT03211338·115 enrolled
Prophylactic Administration of Natural Progesterone in the Prevention of Preterm Delivery in Twin Pregnancies
Completed·UUniversity of Sao Paulo·Phase 4·NCT01031017·390 enrolled
Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT00331695·560 enrolled
The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β
Completed·IIndonesia University·Phase 4·NCT03005496·56 enrolled
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
Completed·UUniversity of Modena and Reggio Emilia·Phase 3·NCT01178788·254 enrolled
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
Completed·—·Phase 2·NCT00141908·290 enrolled
Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?
Completed·—·Phase 2·NCT00329914·677 enrolled
The Impact of Bryophyllum on Preterm Delivery
Completed·UUniversity Hospital, Basel, Switzerland·Phase 4·NCT00163579·26 enrolled
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
Completed·JJohns Hopkins University·Phase 1·NCT02536352·43 enrolled
Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery
Completed·AAMAG Pharmaceuticals, Inc.·Phase 3·NCT01004029·1,740 enrolled
Monocyte Chemotactic Protein-1 (MCP-1) Expressing Monocytes to Predict Preterm Delivery: PhenoMAP Study
Completed·—·N/A·NCT01340222·210 enrolled
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
Completed·GGrünenthal GmbH·Phase 2·NCT02225353·271 enrolled
Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
Terminated·Bbegoña Martinez de Tejada·Phase 3·NCT00536003·384 enrolled
Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
Terminated·UUniversity of Illinois at Chicago·Phase 3·NCT03052270·57 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)